Circulars Grant of WHO GMP COPP through ONDLS Portal (CIRCULARS) Grant of WHO GMP COPP through ONDLS Portal Withdrawal or cancellation of product permission for not Implementing of GSR 327(E); Dated 03.04.2017 (CIRCULARS) Withdrawal or cancellation of product permission for not Implementing of GSR 327(E); Dated 03.04.2017 Manufacturing and marketing of unapproved FDCs VOGLIBOSE AND METFORMIL HCL (CIRCULARS) Manufacturing and marketing of unapproved FDCs VOGLIBOSE AND METFORMIL HCL Action to be taken against the markerter of drugs (CIRCULARS) Action to be taken against the markerter of drugs Display of QR Code and PvPI Toll-Free number in Pharmacy or Chemist Shops across the country to facilitate ADR reporting by consumers (CIRCULARS) Display of QR Code and PvPI Toll-Free number in Pharmacy or Chemist Shops across the country to facilitate ADR reporting by consumers Circular dated 18062025 regarding unapproved FDCs (CIRCULARS) Circular dated 18062025 regarding unapproved FDCs DCGI circular regarding Manufacturing and marketing of unapproved FDCs (CIRCULARS) DCGI circular regarding Manufacturing and marketing of unapproved FDCs Regulatory requirements for outsourcing sterilization activity of medical devices by a manufacturer under Medical Device Rules, 2017 (CIRCULARS) Regulatory requirements for outsourcing sterilization activity of medical devices by a manufacturer under Medical Device Rules, 2017 Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol (CIRCULARS) Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1) (w) of the New Drugs and Clinical Trials Rules, 2019 (CIRCULARS) Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1)(w) of the New Drugs and Clinical Trials Rules, 2019 1 2 3 … 6 ›
